{"id":"usl255","safety":{"commonSideEffects":[{"rate":"null","effect":"Increased risk of atrial fibrillation"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"By inhibiting Nav1.5, USL255 is expected to reduce the risk of atrial fibrillation and subsequent stroke. This mechanism is thought to be beneficial for patients with atrial fibrillation who are at high risk of stroke.","oneSentence":"USL255 is a small molecule that acts as a selective inhibitor of the sodium-activated potassium channel, Nav1.5.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:54:44.041Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Atrial fibrillation for stroke prevention"}]},"trialDetails":[{"nctId":"NCT05925959","phase":"NA","title":"Preoperative Weight Loss for Open Abdominal Wall Reconstruction","status":"RECRUITING","sponsor":"Benjamin T. Miller","startDate":"2023-06-19","conditions":"Abdominal Wall Hernia","enrollment":258},{"nctId":"NCT04986631","phase":"EARLY_PHASE1","title":"Pharmacokinetics and Pharmacodynamics of Topiramate for Weight Loss in Youth: PHARMATOP","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Minnesota","startDate":"2022-04-04","conditions":"Obesity, Childhood","enrollment":62},{"nctId":"NCT06972056","phase":"PHASE4","title":"Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2025-07-09","conditions":"Migraine","enrollment":1335},{"nctId":"NCT01351753","phase":"PHASE2","title":"Drug Therapy Induced Weight Loss to Improve Blood Vessel Function in Subjects With Obesity","status":"TERMINATED","sponsor":"University of Iowa","startDate":"2011-03","conditions":"Obesity, Metabolic Syndrome X","enrollment":128},{"nctId":"NCT07213466","phase":"PHASE4","title":"Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2026-01-19","conditions":"Bipolar I Disorder, Bipolar II Disorder, Schizo Affective Disorder","enrollment":100},{"nctId":"NCT05975580","phase":"PHASE4","title":"Pharmacotherapy in Conjunction With Lifestyle Counseling for Management of Weight Regain After Bariatric Surgery","status":"RECRUITING","sponsor":"University of California, Irvine","startDate":"2023-08-29","conditions":"Obesity","enrollment":120},{"nctId":"NCT07413731","phase":"","title":"Neurophysiological Effects of Medication Tapering During Treatment With Spinal Cord Stimulation","status":"RECRUITING","sponsor":"Brai²n","startDate":"2025-02-03","conditions":"Persistent Spinal Pain Syndrome Type 2 (PSPS-T2), Lower Spine, Spinal Cord Sensitivity to Neurostimulation, Neurophysiological Sensitivity to Spinal Cord Stimulation","enrollment":50},{"nctId":"NCT03511118","phase":"","title":"Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants","status":"RECRUITING","sponsor":"Duke University","startDate":"2018-10-04","conditions":"Lactating Women on Select DOI, Breastfed Infants of Mothers on Select DOI","enrollment":1600},{"nctId":"NCT03461874","phase":"NA","title":"ACT Therapy for HF Migraine","status":"COMPLETED","sponsor":"Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta","startDate":"2018-03-15","conditions":"Migraine Without Aura","enrollment":64},{"nctId":"NCT07384624","phase":"PHASE1, PHASE2","title":"Combining Latency Reversing Agents to Address the HIV Reservoir","status":"NOT_YET_RECRUITING","sponsor":"Erasmus Medical Center","startDate":"2026-04","conditions":"HIV (Human Immunodeficiency Virus), HIV -1 Infection","enrollment":30},{"nctId":"NCT04621929","phase":"PHASE3","title":"Phentermine/Topiramate for Uric Acid Stones","status":"COMPLETED","sponsor":"University of Florida","startDate":"2021-03-31","conditions":"Obesity, Uric Acid Stones, Type 2 Diabetes Mellitus in Obese","enrollment":19},{"nctId":"NCT04050293","phase":"PHASE4","title":"Therapy for Migraine Prevention in Children 6-11 Years of Age","status":"TERMINATED","sponsor":"Supernus Pharmaceuticals, Inc.","startDate":"2020-07-14","conditions":"Migraine Disorders, Headache Disorders","enrollment":26},{"nctId":"NCT05579249","phase":"PHASE4","title":"A Research Study Comparing Wegovy to Other Weight Management Drugs in People Living With Obesity in America","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2023-01-19","conditions":"Obesity","enrollment":500},{"nctId":"NCT00659035","phase":"","title":"Use of Driving Tests to Evaluate Patient Performance on Oral Opioids","status":"ACTIVE_NOT_RECRUITING","sponsor":"Asokumar Buvanendran","startDate":"2008-04","conditions":"Chronic Pain","enrollment":450},{"nctId":"NCT07058155","phase":"PHASE4","title":"Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Disease","status":"RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2025-12-17","conditions":"Liver Cirrhoses, Portal Hypertension Related to Cirrhosis, Severe Obesity","enrollment":70},{"nctId":"NCT05209984","phase":"PHASE3","title":"A Phase 3, Double-blind/Double-dummy, Safety/Efficacy/Superiority of Sibutramine/Topiramate XR in Adults With Overweight","status":"WITHDRAWN","sponsor":"Eurofarma Laboratorios S.A.","startDate":"2026-04","conditions":"Overweight, Obesity","enrollment":""},{"nctId":"NCT06854614","phase":"PHASE4","title":"Sequential or CombinaTion Anti-obesitY Medication With Muscle Preservation for Weight Loss and MaintEnance: A PragmAtic Randomized CoNtrolled Trial (STAY-LEAN Trial)","status":"ACTIVE_NOT_RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2025-03-01","conditions":"Obesity","enrollment":150},{"nctId":"NCT02273804","phase":"PHASE3","title":"Topiramate and Severe Obesity","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2016-06-01","conditions":"Obese Children and Adolescents","enrollment":18},{"nctId":"NCT07027969","phase":"PHASE4","title":"Metabolic Surgery for Atrial Fibrillation Elimination","status":"NOT_YET_RECRUITING","sponsor":"Ali Aminian","startDate":"2026-02-01","conditions":"Atrial Fibrillation, Obesity and Obesity-related Medical Conditions","enrollment":100},{"nctId":"NCT03196466","phase":"","title":"Population Pharmacokinetics of Antiepileptic in Pediatrics","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2017-06-19","conditions":"Epilepsy","enrollment":753},{"nctId":"NCT06303778","phase":"NA","title":"Combining a Smartphone App With Medications to Manage Heavy Drinking","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2024-11-01","conditions":"Alcohol Use Disorder (AUD)","enrollment":330},{"nctId":"NCT01182766","phase":"PHASE2, PHASE3","title":"New Treatment for Alcohol and Nicotine Dependence","status":"COMPLETED","sponsor":"University of Virginia","startDate":"2011-11-01","conditions":"Alcohol Dependence, Nicotine Dependence","enrollment":236},{"nctId":"NCT04881799","phase":"EARLY_PHASE1","title":"Phentermine/Topiramate in Adolescents With Type 2 Diabetes and Obesity","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Minnesota","startDate":"2022-07-07","conditions":"Pediatric Obesity","enrollment":13},{"nctId":"NCT06877572","phase":"","title":"Weight Loss Management in Endometrial Cancer Survivors","status":"RECRUITING","sponsor":"University of Kansas Medical Center","startDate":"2025-03-25","conditions":"Endometrial Cancer Survivors, Weight Management, Early Stage Endometrial Cancer","enrollment":50},{"nctId":"NCT06799169","phase":"PHASE4","title":"Management of Acute Tinnitus With Migraine Medications","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of California, Irvine","startDate":"2025-06-01","conditions":"Tinnitus","enrollment":100},{"nctId":"NCT07203248","phase":"","title":"Chinese Real-world Study of Treatment of Vestibular Migraine","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-12","conditions":"Vestibular Migraine, Dizziness, Vertigo","enrollment":2000},{"nctId":"NCT07188545","phase":"","title":"Using Secondary Data to Evaluate Sex-based Heterogeneity of GLP-1 Agonists and SGLT2 Inhibitors on Cardiovascular-Kidney-Metabolic Health (CKMH) Outcomes in Real-world Settings (DASH-CKMH)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ohio State University","startDate":"2025-09-15","conditions":"Cardiovascular Kidney Metabolic Syndrome","enrollment":23280000},{"nctId":"NCT05756764","phase":"","title":"Anti-obesity Pharmacotherapy and Inflammation","status":"ACTIVE_NOT_RECRUITING","sponsor":"Louisiana State University Health Sciences Center in New Orleans","startDate":"2023-06-01","conditions":"Obesity","enrollment":30},{"nctId":"NCT02670161","phase":"PHASE4","title":"Quality Improvement and Practice Based Research in Neurology Using the EMR","status":"ENROLLING_BY_INVITATION","sponsor":"Endeavor Health","startDate":"2016-05","conditions":"Brain Tumors, Epilepsy, Migraine","enrollment":3300},{"nctId":"NCT05756621","phase":"","title":"Dual Anti-glutamate Therapy in Super-refractory Status Epilepticus After Cardiac Arrest","status":"RECRUITING","sponsor":"University of Milano Bicocca","startDate":"2022-01-15","conditions":"Status Epilepticus, Cardiac Arrest","enrollment":80},{"nctId":"NCT06299891","phase":"PHASE2","title":"Efficacy and Safety of Phentermine/Topiramate in Youth With Hypothalamic Obesity","status":"RECRUITING","sponsor":"Seattle Children's Hospital","startDate":"2025-03-01","conditions":"Hypothalamic Obesity, Hypothalamic Tumor, Craniopharyngioma","enrollment":24},{"nctId":"NCT04007393","phase":"PHASE2","title":"SMART Use of Medication for the Treatment of Adolescent Severe Obesity","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2019-11-21","conditions":"Adolescent Obesity","enrollment":150},{"nctId":"NCT03689114","phase":"PHASE4","title":"Low vs. Standard Daily Doses of Antiepileptic Drugs in Newly Diagnosed, Previously Untreated Epilepsy(STANDLOW)","status":"COMPLETED","sponsor":"Mario Negri Institute for Pharmacological Research","startDate":"2021-05-10","conditions":"Epilepsies, Partial","enrollment":58},{"nctId":"NCT04572217","phase":"PHASE2","title":"Medications After Adolescent Bariatric Surgery","status":"WITHDRAWN","sponsor":"Janey Pratt","startDate":"2022-06-01","conditions":"Pediatric Obesity","enrollment":""},{"nctId":"NCT05748483","phase":"PHASE3","title":"Comparative Study of Oral Atogepant Versus Oral Topiramate to Assess Adverse Events in Adult Participants With Migraine","status":"ACTIVE_NOT_RECRUITING","sponsor":"AbbVie","startDate":"2023-10-07","conditions":"Migraine","enrollment":545},{"nctId":"NCT04095104","phase":"PHASE2","title":"Adjunct Phentermine + Topiramate After Bariatric Surgery in 12-24 Year Olds","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2020-01-15","conditions":"Obesity, Morbid, Bariatric Surgery, Adolescent","enrollment":13},{"nctId":"NCT02201251","phase":"PHASE3","title":"A Study to Investigate the Safety of the Drugs Topiramate and Levetiracetam in Treating Children Recently Diagnosed With Epilepsy","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2014-10-06","conditions":"Epilepsy","enrollment":63},{"nctId":"NCT04298203","phase":"PHASE2","title":"Role of Pharmacotherapy in Counteracting Weight Regain in Adolescents With Severe Obesity","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Minnesota","startDate":"2021-08-04","conditions":"Obesity","enrollment":100},{"nctId":"NCT04613024","phase":"EARLY_PHASE1","title":"Beneficial Side Effects of Topiramate in Obese Patients Undergoing Total Joint Arthroplasty","status":"WITHDRAWN","sponsor":"Stanford University","startDate":"2025-07-01","conditions":"Weight Loss, Pain, Postoperative","enrollment":""},{"nctId":"NCT02283814","phase":"PHASE1","title":"A Open-label, Drug Interaction Study Between Eslicarbazepine Acetate and Topiramate","status":"COMPLETED","sponsor":"Bial - Portela C S.A.","startDate":"2007-01","conditions":"Epilepsy","enrollment":32},{"nctId":"NCT00394095","phase":"PHASE4","title":"Topiramate vs. Placebo in Preventing Weight Gain in Bipolar Disorder Treated With Olanzapine","status":"COMPLETED","sponsor":"University of Cincinnati","startDate":"2006-12","conditions":"Bipolar Disorder, Weight Gain","enrollment":31},{"nctId":"NCT03667846","phase":"PHASE2","title":"Leveraging Biomarkers for Personalized Treatment of Alcohol Use Disorder Comorbid With PTSD","status":"RECRUITING","sponsor":"NYU Langone Health","startDate":"2019-10-10","conditions":"Post Traumatic Stress Disorder, Alcohol Use Disorder","enrollment":150},{"nctId":"NCT05209997","phase":"","title":"Observational, Real-life, Retrospective, Data Collection, Use Sibutramine/topiramate in Overweight Comorbidities/obesity","status":"WITHDRAWN","sponsor":"Eurofarma Laboratorios S.A.","startDate":"2024-12-01","conditions":"Overweight, Obesity","enrollment":""},{"nctId":"NCT04581603","phase":"PHASE4","title":"CBT-I Augmentation of Medication for Drinking in AUD","status":"TERMINATED","sponsor":"VA Office of Research and Development","startDate":"2022-06-15","conditions":"Alcohol Use Disorder With Insomnia","enrollment":82},{"nctId":"NCT05812183","phase":"PHASE4","title":"Gastric Sleeve-Induced Weight Loss on Shortness of Breath in Obesity","status":"WITHDRAWN","sponsor":"University of California, Los Angeles","startDate":"2023-07-09","conditions":"Dyspnea, Quality of Life","enrollment":""},{"nctId":"NCT03307863","phase":"PHASE4","title":"Effect of Anti-epileptic Drugs on Etonogestrel-releasing Implant Pharmacokinetics in Women With Epilepsy","status":"SUSPENDED","sponsor":"University of Sao Paulo","startDate":"2017-11-01","conditions":"Contraception, Drug Interactions","enrollment":69},{"nctId":"NCT03671681","phase":"PHASE4","title":"Mindfulness Therapy for Chronic Migraine","status":"COMPLETED","sponsor":"Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta","startDate":"2018-11-05","conditions":"Chronic Migraine, Medication Overuse Headache","enrollment":177},{"nctId":"NCT06322407","phase":"NA","title":"Ultrasound-guided Stellate Ganglion Block for Treatment of Chronic Migraine in Adult","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2024-06-01","conditions":"Chronic Migraine","enrollment":206},{"nctId":"NCT05263674","phase":"PHASE3","title":"Fast Acute Sedation at Intensive Care vs. High-dose i.v. Anti-seizure Medication for Treatment of Non-convulsive Status Epilepticus (FAST-trial)","status":"RECRUITING","sponsor":"University of Southern Denmark","startDate":"2022-02-07","conditions":"Non-Convulsive Status Epilepticus","enrollment":140},{"nctId":"NCT01689649","phase":"PHASE4","title":"A Study to Assess Tolerability and Efficacy of Topiramate Monotherapy in Recently Diagnosed Patients With Epilepsy","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2008-05-02","conditions":"Epilepsy","enrollment":139},{"nctId":"NCT01950520","phase":"PHASE2","title":"Study of Human Non-Shivering Thermogenesis and Basal Metabolic Rate","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2014-02-07","conditions":"Healthy Volunteers","enrollment":47},{"nctId":"NCT00904943","phase":"PHASE1","title":"Topiramate 25 mg Capsules Under Fed Conditions","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2002-06","conditions":"Healthy","enrollment":18},{"nctId":"NCT04531176","phase":"PHASE4","title":"EMI-EHP Weight Management and Type 2 Diabetes Pragmatic Trial","status":"TERMINATED","sponsor":"The Cleveland Clinic","startDate":"2020-09-01","conditions":"Type 2 Diabetes, Obesity","enrollment":74},{"nctId":"NCT00905164","phase":"PHASE1","title":"Topiramate 25 mg Capsules Under Fasting Conditions","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2002-06","conditions":"Healthy","enrollment":24},{"nctId":"NCT00905346","phase":"PHASE1","title":"Topiramate 25 mg Capsule Mixed With Applesauce Under Fasting Conditions","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2002-06","conditions":"Healthy","enrollment":24},{"nctId":"NCT00905606","phase":"PHASE1","title":"Topiramate 25 mg Tablets Under Fasting Conditions","status":"COMPLETED","sponsor":"Teva Pharmaceuticals USA","startDate":"2001-06","conditions":"Healthy","enrollment":30},{"nctId":"NCT05582837","phase":"PHASE4","title":"Treatment of Meniere's Disease With Migraine Medications","status":"RECRUITING","sponsor":"University of California, Irvine","startDate":"2022-08-01","conditions":"Ménière","enrollment":100},{"nctId":"NCT05215418","phase":"PHASE4","title":"A Study of VI-0521 on Ambulatory Blood Pressure (ABPM) in Overweight or Obese Subjects","status":"COMPLETED","sponsor":"VIVUS LLC","startDate":"2022-01-25","conditions":"Blood Pressure","enrollment":565},{"nctId":"NCT06248931","phase":"PHASE3","title":"Valproate Versus Topiramate in Migraine","status":"COMPLETED","sponsor":"Kafrelsheikh University","startDate":"2022-05-01","conditions":"Migraine Disorders","enrollment":600},{"nctId":"NCT06499116","phase":"PHASE4","title":"Comparison of the Effectiveness of First-line Preventive Treatment of Migraine in Primary Care","status":"NOT_YET_RECRUITING","sponsor":"Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina","startDate":"2024-10","conditions":"Migraine","enrollment":460},{"nctId":"NCT01765218","phase":"PHASE1, PHASE2","title":"Topiramate in Neonates Receiving Whole Body Cooling for Hypoxic Ischemic Encephalopathy","status":"TERMINATED","sponsor":"Kristin R Hoffman","startDate":"2013-02","conditions":"Hypoxic Ischemic Encephalopathy","enrollment":34},{"nctId":"NCT00812006","phase":"PHASE3","title":"A Study of Rizatriptan for the Treatment of Acute Migraine in Patients on Topiramate for Migraine Prophylaxis","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2009-03-24","conditions":"Migraine","enrollment":108},{"nctId":"NCT06347497","phase":"PHASE3","title":"Zonisamide Versus Topiramate in Migraine","status":"RECRUITING","sponsor":"Kafrelsheikh University","startDate":"2024-04-01","conditions":"Migraine","enrollment":600},{"nctId":"NCT00649740","phase":"PHASE1","title":"Fasting Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg","status":"COMPLETED","sponsor":"Mylan Pharmaceuticals Inc","startDate":"2005-11","conditions":"Healthy","enrollment":36},{"nctId":"NCT00648934","phase":"PHASE1","title":"Fed Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg","status":"COMPLETED","sponsor":"Mylan Pharmaceuticals Inc","startDate":"2005-11","conditions":"Healthy","enrollment":36},{"nctId":"NCT00649467","phase":"PHASE1","title":"Applesauce Study of Topiramate Sprinkle Capsules 25 mg and Topamax® Sprinkle Capsules 25 mg","status":"COMPLETED","sponsor":"Mylan Pharmaceuticals Inc","startDate":"2005-11","conditions":"Healthy","enrollment":35},{"nctId":"NCT00606411","phase":"EARLY_PHASE1","title":"Efficacy and Safety of Topiramate in the Treatment of Sleep-Related Eating Disorder","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2008-01","conditions":"Sleep-Related Eating Disorder","enrollment":34},{"nctId":"NCT06243692","phase":"PHASE3","title":"Lacosamide Versus Topiramate in Migraine","status":"RECRUITING","sponsor":"Kafrelsheikh University","startDate":"2024-02-01","conditions":"Migraine Disorders","enrollment":600},{"nctId":"NCT06282783","phase":"PHASE1, PHASE2","title":"Studying Topiramate for Re-Activating the HIV-1 Reservoir","status":"UNKNOWN","sponsor":"Erasmus Medical Center","startDate":"2024-09","conditions":"HIV-1-infection, Hiv, HIV Infections","enrollment":12},{"nctId":"NCT05403229","phase":"PHASE2","title":"The Role of Migraine Prophylaxis Agent Topiramate in Treating Patients With Sudden Sensorineural Hearing Loss","status":"UNKNOWN","sponsor":"Chang Gung Memorial Hospital","startDate":"2022-10-17","conditions":"Sudden Deafness, Sudden Sensorineural Hearing Loss","enrollment":140},{"nctId":"NCT05378503","phase":"PHASE4","title":"Phase IV Study of Qsymia in Obese Patients","status":"COMPLETED","sponsor":"Alvogen Korea","startDate":"2021-09-17","conditions":"Obesity","enrollment":232},{"nctId":"NCT03176953","phase":"PHASE2, PHASE3","title":"Topiramate and Prolonged Exposure","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2017-11-01","conditions":"PTSD and Alcohol Use Disorder","enrollment":100},{"nctId":"NCT02878798","phase":"PHASE2","title":"Topiramate for Cryptogenic Sensory Peripheral Neuropathy in Metabolic Syndrome (CSPN)","status":"COMPLETED","sponsor":"Virginia Commonwealth University","startDate":"2018-02-12","conditions":"Cryptogenic Sensory Peripheral Neuropathy in Metabolic Syndrome","enrollment":132},{"nctId":"NCT05940935","phase":"","title":"The Relationship of Developing Metabolic Acidosis With Antiepleptic Drugs in Craniotomy Operations","status":"COMPLETED","sponsor":"Trakya University","startDate":"2023-05-22","conditions":"Metabolic Acidosis, Antiepileptic Drugs, Craniotomy","enrollment":35},{"nctId":"NCT05834062","phase":"PHASE2","title":"Phentermine/Topiramate as Preventive Pharmacotherapy for Obesity","status":"WITHDRAWN","sponsor":"University of Minnesota","startDate":"2023-10-17","conditions":"Obesity, Adolescent","enrollment":""},{"nctId":"NCT06089356","phase":"PHASE4","title":"Zolmitriptane as Prophylaxis for Chilhood Migraine","status":"UNKNOWN","sponsor":"Tanta University","startDate":"2023-01-01","conditions":"Migraine","enrollment":90},{"nctId":"NCT05663749","phase":"PHASE4","title":"Topiramate vs Metformin on Cardio-Metabolic Profile in Schizophrenia on Atypical Antipsychotics","status":"COMPLETED","sponsor":"All India Institute of Medical Sciences, Bhubaneswar","startDate":"2022-09-20","conditions":"Metabolic Syndrome, Schizophrenia","enrollment":60},{"nctId":"NCT05958160","phase":"PHASE2, PHASE3","title":"Modified Atkins Diet Versus Topiramate In Children With Epileptic Spasms Refractory To Hormonal Treatment: A Randomized Open-Label Study","status":"UNKNOWN","sponsor":"Lady Hardinge Medical College","startDate":"2023-07-20","conditions":"Epileptic Spasms, Failed Hormonal Therapy","enrollment":70},{"nctId":"NCT02808533","phase":"NA","title":"Topiramate and Schizophrenia: Effects on Weight and Psychopathology","status":"UNKNOWN","sponsor":"Centre for Addiction and Mental Health","startDate":"2016-05","conditions":"Schizophrenia, Schizoaffective Disorder","enrollment":50},{"nctId":"NCT03374956","phase":"PHASE3","title":"Individualized Obesity Pharmacotherapy","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2017-12-11","conditions":"Obesity","enrollment":193},{"nctId":"NCT04408586","phase":"PHASE4","title":"Anti-Obesity Phentermine-Topiramate Extended Release Pharmacotherapy vs Placebo Among Patients Using a Wearable Activity Tracker","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2020-06-03","conditions":"Obesity","enrollment":80},{"nctId":"NCT05860062","phase":"NA","title":"Vitamin D Supplementation in Episodic and Chronic Tension-type Headache","status":"UNKNOWN","sponsor":"Hospital de Especialidades, Centro Medico Nacional \"La Raza\", Instituto Mexicano del Seguro Social","startDate":"2023-04-18","conditions":"Chronic Tension-Type Headache","enrollment":20},{"nctId":"NCT04721873","phase":"PHASE2","title":"Pharmacologic Weight Loss as Adjunct Therapy for Ulcerative Colitis in Obese Patients","status":"RECRUITING","sponsor":"University of California, San Diego","startDate":"2020-12-18","conditions":"Colitis, Ulcerative, Obesity","enrollment":40},{"nctId":"NCT03018704","phase":"PHASE4","title":"Topiramate Treatment of Alcohol Use Disorders in African Americans","status":"TERMINATED","sponsor":"VA Office of Research and Development","startDate":"2017-08-01","conditions":"Alcohol Use Disorder","enrollment":79},{"nctId":"NCT05759845","phase":"PHASE4","title":"Topiramate, Amitriptyline Monotherapy and Combination Therapy in Migraine Prophylaxis","status":"UNKNOWN","sponsor":"Dr. Reaz Mahmud","startDate":"2022-08-22","conditions":"Migraine","enrollment":150},{"nctId":"NCT03603080","phase":"PHASE4","title":"Efficacy of Pharmacotherapy to Enhance Weight Loss Following Sleeve Gastrectomy","status":"TERMINATED","sponsor":"Hartford Hospital","startDate":"2019-03-01","conditions":"Obesity","enrollment":12},{"nctId":"NCT04404439","phase":"PHASE4","title":"Treatment of Tinnitus With Migraine Medications","status":"RECRUITING","sponsor":"University of California, Irvine","startDate":"2019-09-26","conditions":"Tinnitus, Subjective, Tinnitus","enrollment":150},{"nctId":"NCT03799198","phase":"PHASE4","title":"Real World Effectiveness of Combining an Employer-based Weight Management Program With Medication for Chronic Weight Management in Employees With Obesity","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2019-01-07","conditions":"Obesity","enrollment":200},{"nctId":"NCT03922945","phase":"PHASE4","title":"A Phase IV Safety and Efficacy Study of VI-0521 in Adolescents With Obesity","status":"COMPLETED","sponsor":"VIVUS LLC","startDate":"2019-05-02","conditions":"Adolescent Obesity, Obesity in Adolescence, Adolescent Overweight","enrollment":223},{"nctId":"NCT05516251","phase":"NA","title":"Transcutaneous Supraorbital Nerve Stimulator Versus Topiramate in Prevention of Recurrent Migraine","status":"UNKNOWN","sponsor":"Tongji Hospital","startDate":"2021-10-01","conditions":"Migraine, Classic","enrollment":200},{"nctId":"NCT02714062","phase":"PHASE4","title":"A Pharmacokinetic Study Comparing VI-0521 With Placebo in Obese Adolescents","status":"COMPLETED","sponsor":"VIVUS LLC","startDate":"2016-03","conditions":"Pediatric Obesity, Childhood Obesity","enrollment":42},{"nctId":"NCT03335163","phase":"PHASE1","title":"The Effect of Topiramate on Etonogestrel Concentrations in Contraceptive Implant Users","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2018-03-15","conditions":"Migraine, Migraine;Menstrual, Contraception","enrollment":48},{"nctId":"NCT03636958","phase":"NA","title":"Efficacy and Safety of Perampanel in Combination in Glioma-refractory Epilepsy","status":"WITHDRAWN","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2021-02-15","conditions":"Refractory Epilepsy","enrollment":""},{"nctId":"NCT02497443","phase":"PHASE1, PHASE2","title":"Safety of Autologous MSC Infusion to Treat Epilepsy","status":"COMPLETED","sponsor":"Ministry of Public Health, Republic of Belarus","startDate":"2011-04","conditions":"Epilepsy","enrollment":60},{"nctId":"NCT01408641","phase":"NA","title":"Topiramate for Alcohol Use in Posttraumatic Stress Disorder","status":"TERMINATED","sponsor":"University of Maryland, Baltimore","startDate":"2012-09","conditions":"Alcohol Dependence, Alcoholism, Alcohol Abuse","enrollment":4},{"nctId":"NCT05236166","phase":"NA","title":"Multicentre Study on Rapid Versus Slow Withdrawal of Antiepileptic Monotherapy","status":"COMPLETED","sponsor":"University Magna Graecia","startDate":"2017-04-26","conditions":"Epilepsy","enrollment":48},{"nctId":"NCT02371889","phase":"PHASE2","title":"A Randomized, Double-blind Placebo-Controlled Pharmacogenetic Study of Topiramate in European-American Heavy Drinkers","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2014-12-18","conditions":"Alcoholism, Alcohol Use Disorder (AUD)","enrollment":320},{"nctId":"NCT04523935","phase":"PHASE4","title":"Excessive Crying in Children With Cerebral Palsy and Communication Deficits","status":"COMPLETED","sponsor":"Sathbhavana Brain Clinic","startDate":"2005-12-07","conditions":"Cerebral Palsy, Excessive Crying, Pain","enrollment":131},{"nctId":"NCT03828539","phase":"PHASE4","title":"Head-to-head Study of Erenumab Against Topiramate in Patients With Episodic and Chronic Migraine","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2019-02-22","conditions":"Migraine","enrollment":777},{"nctId":"NCT02113787","phase":"NA","title":"Switchability Study Between Brand and Generic Topiramate","status":"COMPLETED","sponsor":"Seoul National University Hospital","startDate":"2014-02","conditions":"Epilepsy","enrollment":24}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":11,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Topiramate extended-release"],"phase":"phase_3","status":"active","brandName":"USL255","genericName":"USL255","companyName":"Upsher-Smith Laboratories","companyId":"upsher-smith-laboratories","modality":"Small molecule","firstApprovalDate":"","aiSummary":"USL255 is a small molecule that acts as a selective inhibitor of the sodium-activated potassium channel, Nav1.5. Used for Atrial fibrillation for stroke prevention.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}